Cite
HARVARD Citation
Hu, Q. et al. (2022). Role of CDK4/6 inhibitors in patients with hormone receptor (HR)-positive, human epidermal receptor-2 negative (HER-2) metastatic breast cancer study protocol for a systematic review, network meta-analysis and cost-effectiveness analysis. BMJ open. 12 (5), p. . [Online].